Ikena Oncology has filed a notice of an exempt offering of securities to raise $42,571,751.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Ikena Oncology is raising $42,571,751.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mark Manfredi played a key role…